Full-Time

Software Engineer I

Neuro

Posted on 3/24/2025

Medtronic

Medtronic

10,001+ employees

Develops and manufactures medical devices and therapies

Compensation Overview

$74.4k - $111.6k/yr

+ Short-term Incentive Plan

Entry

Minneapolis, MN, USA

Category
Full-Stack Engineering
Mobile Engineering
Software Engineering
Required Skills
Agile
Java
Android Development
Requirements
  • Bachelors Degree in Computer Science with 0 years of experience
Responsibilities
  • Design, build, and test web applications in global cloud infrastructure as a service environment
  • Design, build, and test Android applications
  • Design, build, and test embedded Java applications
  • Develop in an agile environment, working with agile teams in multiple sites
  • Create and document all aspects of the software engineering processes for products under development, incorporating the highest quality standards, cost effectiveness, and measurable efficiency
  • Meet all project milestones and deliverables, as required by the project leadership
  • Provide concise, timely, and accurate reports and status of all development and test activities
  • Participate in continuous process improvement activities
  • Keep abreast of technical and industry trends related to software design and development
Desired Qualifications
  • Coding experience through school projects, internship or work experience
  • Working knowledge of Java, Kotlin, and JavaScript
  • Knowledgeable in Object Oriented Design and Design Patterns
  • Experience in web frameworks– Spring, JPA, Hibernate, Angular, RxJS
  • Experience with relational databases (MySQL, PostgreSQL) and data modeling
  • Experience in Android development
  • Experience in testing frameworks – JUnit, Appium, Selenium
  • Strong leadership and team commitment
  • Effective communication and presentation skills

Medtronic provides medical technology, services, and solutions to improve patient care. The company develops a variety of medical devices, including pacemakers, insulin pumps, surgical tools, and neurostimulation devices, which help diagnose, prevent, and treat chronic diseases. These products are used by hospitals, clinics, and healthcare professionals around the world. Medtronic stands out from competitors by investing heavily in research and development to create new products and offering additional services like training and patient management programs. The goal of Medtronic is to enhance patient outcomes and lower healthcare costs through its comprehensive range of medical solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Fridley, Minnesota

Founded

1949

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing wearable medical devices market offers expansion opportunities in diabetes and cardiovascular monitoring.
  • Increased demand for minimally invasive surgeries aligns with Medtronic's advanced surgical tools.
  • IoT integration in medical devices enhances remote patient monitoring capabilities for Medtronic.

What critics are saying

  • Emerging Asian medical device companies threaten Medtronic's market share with cost-effective solutions.
  • Global semiconductor shortage may delay Medtronic's supply chain and product availability.
  • FDA's increased scrutiny could slow down Medtronic's product launch timelines.

What makes Medtronic unique

  • Medtronic's AI-powered Touch Surgery platform enhances personalized and efficient patient care.
  • The Evolut TAVR system offers a durable alternative to surgery for aortic stenosis.
  • Medtronic's comprehensive suite of products and services improves patient outcomes and reduces costs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Employee Assistance Program

Wellness Program

Company News

PR Newswire
Mar 30th, 2025
Medtronic Evolut™ Tavr System Shows Durable Clinical Outcomes And Outstanding Valve Performance At Five Years In Low-Risk Aortic Stenosis Patients

GALWAY, Ireland and CHICAGO, March 30, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years, strong valve performance and durable clinical outcomes. The findings were presented as late-breaking clinical science at the American College of Cardiology's Annual Scientific Session & Expo and simultaneously published in the JACC, the flagship journal of the American College of Cardiology.The Evolut Low Risk Trial was a randomized, multicenter, international study assessing the safety and efficacy of the Evolut TAVR system versus surgery in low-risk patients. These patients had a predicted 30-day mortality risk <3%, as assessed by a local heart team. 1,414 patients were randomized, with 730 receiving TAVR with either a Medtronic Evolut R, PRO, or CoreValve™ and 684 undergoing surgery."Results at five years support Evolut's supra-annular, self-expanding TAVR as a safe, effective, and durable alternative to surgery for patients with severe aortic stenosis, regardless of their surgical risk," said Michael J. Reardon, M.D., Allison Family Distinguished Chair of Cardiovascular Research and professor of cardiothoracic surgery at the Houston Methodist Hospital and principal investigator of the trial

The Gulf Press
Mar 28th, 2025
Global Medical Robotics and Computer-Assisted Surgery Market is expected to reach US$ 23.6 billion by 2033

Additionally, in July 2024, Medtronic introduced the Live Stream function for its Touch Surgery digital technology ecosystem, incorporating AI-powered capabilities.

Ammons Law Firm
Mar 26th, 2025
Medtronic Recalls Embolization Devices Linked to Injuries and Deaths

Medtronic has issued a recall of certain embolization devices following reports of 17 injuries and four deaths, according to the U.S. Food and Drug Administration (FDA).

Zahrawi Group
Mar 25th, 2025
Pan Arab Spine Conference 2025

Zahrawi Group, in partnership with Medtronic, proudly participated as a gold sponsor at the prestigious Pan Arab Spine Conference 2025, held at the ritz-carlton, DIFC, dubai.

Zahrawi Group
Mar 25th, 2025
Dubai Hernia Summit 2025 Platinum Sponsors

Zahrawi Group is proud to participate in the Dubai Hernia Summit 2025 alongside its esteemed partner, Medtronic, as Platinum Sponsors.

INACTIVE